New York Life Investment Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,249
Closed -$356K 1006
2024
Q1
$356K Buy
+20,249
New +$356K ﹤0.01% 1260